PeopleBio will change its company name to “TimeX AI” and make a full-scale entry into the artificial intelligence (AI) infrastructure business.
Show original image
PeopleBio announced on July 6th that it will hold an extraordinary general meeting of shareholders on July 20th and propose proposals such as changing the company name, 2-for-1 reverse stock split, and appropriating 79.2 billion won in capital surplus to cover the accumulated deficit.
The company name will change to TimeX AI, reflecting the company’s goal to become a leading AI-based company. PeopleBio currently focuses on AI data center infrastructure, servers, semiconductors, and biotechnology fields as its main business areas.
With Samsung Electronics and SK Hynix building semiconductor factories and data center infrastructure, TimeX AI is expected to benefit in the AI infrastructure and server sector. In the semiconductor field, our remanufacturing partner SYSTAR has been in discussions regarding the purchase and delivery of used 200mm wafer equipment that we plan to supply to mid-sized foundry companies in Japan. In the biotechnology field, the company is accelerating efforts to have its products designated as breakthrough medical devices by the U.S. Food and Drug Administration (FDA).
Today’s featured products
“KOSPI’s fate depends on Samsung’s profits: Will the ‘surge’ resume, aiming for 99 trillion won in profits?”
A PeopleBio representative said, “We will use the extraordinary general meeting on July 20th as an opportunity to accelerate our transformation into an AI infrastructure company.” “We will produce tangible results in our three major business areas and expand new foundations for growth,” the official said.
This content was created with the help of: AI translation service.
©Asia Business Daily. Unauthorized reproduction is prohibited. Unauthorized training and use of AI is prohibited.
